{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:13:41Z","timestamp":1768817621053,"version":"3.49.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mitochondrion"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.mito.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T02:01:30Z","timestamp":1553047290000},"page":"318-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Sonal","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mito.2019.03.004_bb0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12035-014-8696-7","article-title":"Cypermethrin-induced nigrostriatal dopaminergic neurodegeneration alters the mitochondrial function: a proteomics study","volume":"51","author":"Agrawal","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mito.2019.03.004_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2018.04.002","article-title":"Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically","volume":"120","author":"Agrawal","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2019.03.004_bb0015","article-title":"Dysfunctional mitochondrial respiration in the striatum of the Huntington's disease transgenic R6\/2 mouse model","volume":"5","author":"Aidt","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.mito.2019.03.004_bb0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1046\/j.1471-4159.2000.0750840.x","article-title":"No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease","volume":"75","author":"Alam","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mito.2010.07.002","article-title":"Nuclear coded mitochondrial protein prohibitin is an iron regulated iron binding protein","volume":"11","author":"Ande","year":"2011","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2019.03.004_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","article-title":"p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease","volume":"47","author":"Bae","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.mito.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddq018","article-title":"Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis","volume":"19","author":"Becanovic","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JHD-150182","article-title":"Neonatal Iron supplementation induces striatal atrophy in female YAC128 Huntington's disease mice","volume":"5","author":"Berggren","year":"2016","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.mito.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/j.1471-4159.1985.tb07192.x","article-title":"Regional mitochondrial respiratory activity in Huntington's disease brain","volume":"44","author":"Brennan","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/rej.2015.1736","article-title":"Time-course analysis of protein and lipid oxidation in the brains of Yac128 Huntington's disease transgenic mice","volume":"19","author":"Brocardo","year":"2016","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0065","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1093\/hmg\/ddq370","article-title":"Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis","volume":"19","author":"Burbulla","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1021\/pr101211k","article-title":"Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex 1 inhibition","volume":"10","author":"Burte","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"44531","DOI":"10.1074\/jbc.M206525200","article-title":"Mitochondrial Hsp60, resistance to oxidative stress, and the labile iron pool are closely connected in Saccharomyces cerevisiae","volume":"277","author":"Cabiscol","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2019.03.004_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbabio.2013.11.010","article-title":"Mitochondrial dismissal in mammals, from protein degradation to mitophagy","volume":"1837","author":"Campello","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/1522-2683(200206)23:11<1745::AID-ELPS1745>3.0.CO;2-A","article-title":"Inhibition of unwanted proteolysis during sample preparation: evaluation of its efficiency in challenge experiments","volume":"23","author":"Castellanos-Serra","year":"2002","journal-title":"Electrophoresis"},{"key":"10.1016\/j.mito.2019.03.004_bb0090","article-title":"Proteomics: challenges, techniques and possibilities to overcome biological sample complexity","volume":"2009","author":"Chandramouli","year":"2009","journal-title":"Hum Genomics Proteomics"},{"key":"10.1016\/j.mito.2019.03.004_bb0095","article-title":"Iron accumulates in Huntington's disease neurons: protection by deferoxamine","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mito.2019.03.004_bb0100","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jprot.2015.11.007","article-title":"Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology","volume":"132","author":"Choudhury","year":"2016","journal-title":"J. Proteome"},{"key":"10.1016\/j.mito.2019.03.004_bb0110","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1128\/MCB.05393-11","article-title":"Stomatin-like protein 2 binds cardiolipin and regulates mitochondrial biogenesis and function","volume":"31","author":"Christie","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mito.2019.03.004_bb0115","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1021\/bi900558g","article-title":"Redox potential and peroxide reactivity of human peroxiredoxin 3","volume":"48","author":"Cox","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.mito.2019.03.004_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mito.2019.03.004_bb0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.brainresbull.2011.01.012","article-title":"Proteomic changes in the brains of Huntington's disease mouse models reflect pathology and implicate mitochondrial changes","volume":"88","author":"Deschepper","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.mito.2019.03.004_bb0130","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/iub.357","article-title":"Neurogranin, a link between calcium\/calmodulin and protein kinase C signaling in synaptic plasticity","volume":"62","author":"Diez-Guerra","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.mito.2019.03.004_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/152308603322110896","article-title":"Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease","volume":"5","author":"Ebadi","year":"2003","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.mito.2019.03.004_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1083\/jcb.143.1.217","article-title":"Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions","volume":"143","author":"Eskes","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mito.2019.03.004_bb0145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nm.3617","article-title":"Huntington's disease is a four-repeat tauopathy with tau nuclear rods","volume":"20","author":"Fernandez-Nogales","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.mito.2019.03.004_bb0150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbadis.2009.04.001","article-title":"Mouse models of Huntington's disease and methodological considerations for therapeutic trials","volume":"1792","author":"Ferrante","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2019.03.004_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","article-title":"Bioenergetic dysfunction in Huntington's disease human cybrids","volume":"231","author":"Ferreira","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.arr.2009.03.003","article-title":"The coordination of nuclear and mitochondrial communication during aging and calorie restriction","volume":"8","author":"Finley","year":"2009","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mito.2019.03.004_bb0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1326-5-26","article-title":"The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"5","author":"Fox","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mito.2019.03.004_bb0170","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/hmg\/ddu456","article-title":"Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease","volume":"24","author":"Gratuze","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0180","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's disease collaborative research group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mito.2019.03.004_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0190","doi-asserted-by":"crossref","first-page":"12646","DOI":"10.1038\/ncomms12646","article-title":"VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease","volume":"7","author":"Guo","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mito.2019.03.004_bb0195","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/hmg\/ddv209","article-title":"Oxidative metabolism in YAC128 mouse model of Huntington's disease","volume":"24","author":"Hamilton","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0200","first-page":"2762","article-title":"Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington's disease","volume":"25","author":"Hamilton","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1212\/WNL.50.4.1033","article-title":"Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases","volume":"50","author":"Hoang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2019.03.004_bb0210","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0215","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.mito.2019.03.004_bb0220","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.yexcr.2008.01.005","article-title":"Human prohibitin 1 maintains the organization and stability of the mitochondrial nucleoids","volume":"314","author":"Kasashima","year":"2008","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/dnares\/6.5.291","article-title":"Characterization of the human dihydropyrimidinase-related protein 2 (DRP-2) gene","volume":"6","author":"Kitamura","year":"1999","journal-title":"DNA Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0230","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0092-8674(92)90086-R","article-title":"Antifolding activity of hsp60 couples protein import into the mitochondrial matrix with export to the intermembrane space","volume":"68","author":"Koll","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.mito.2019.03.004_bb0235","first-page":"5","article-title":"Increased Body Weight of the BAC HD Transgenic Mouse Model of Huntington's Disease Accounts for Some but Not All of the Observed HD-like Motor Deficits","author":"Kudwa","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.mito.2019.03.004_bb0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nn.4256","article-title":"Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice","volume":"19","author":"Langfelder","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mito.2019.03.004_bb0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-005-2996-1","article-title":"Effect of GRP75\/mthsp70\/PBP74\/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells","volume":"268","author":"Liu","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/biom2010143","article-title":"Mortalin, apoptosis, and neurodegeneration","volume":"2","author":"Londono","year":"2012","journal-title":"Biomolecules"},{"key":"10.1016\/j.mito.2019.03.004_bb0255","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0260","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1021\/pr500649m","article-title":"Proteomics of Huntington's disease-affected human embryonic stem cells reveals an evolving pathology involving mitochondrial dysfunction and metabolic disturbances","volume":"13","author":"McQuade","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1749-6632.2000.tb06649.x","article-title":"Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging","volume":"908","author":"Melov","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mito.2019.03.004_bb0270","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mito.2019.03.004_bb0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbamcr.2008.05.013","article-title":"Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis","volume":"1793","author":"Merkwirth","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2019.03.004_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003021","article-title":"Loss of prohibitin membrane scaffolds impairs mitochondrial architecture and leads to tau hyperphosphorylation and neurodegeneration","volume":"8","author":"Merkwirth","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0285","doi-asserted-by":"crossref","first-page":"D183","DOI":"10.1093\/nar\/gkw1138","article-title":"PANTHER version 11: expanded annotation data from gene ontology and Reactome pathways, and data analysis tool enhancements","volume":"45","author":"Mi","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0290","doi-asserted-by":"crossref","first-page":"30773","DOI":"10.1074\/jbc.M504749200","article-title":"Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin","volume":"280","author":"Milakovic","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2019.03.004_bb0295","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.25009","article-title":"Abnormal response to cortical activation in early stages of Huntington disease","volume":"27","author":"Mochel","year":"2012","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.mito.2019.03.004_bb0300","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1007\/s12035-016-0048-3","article-title":"Comparative mitochondrial-based protective effects of resveratrol and Nicotinamide in Huntington's disease models","volume":"54","author":"Naia","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.mito.2019.03.004_bb0305","doi-asserted-by":"crossref","first-page":"743","DOI":"10.15252\/msb.20145304","article-title":"Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases","volume":"10","author":"Narayanan","year":"2014","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mito.2019.03.004_bb0310","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/NEN.0000000000000197","article-title":"Abnormalities in the tricarboxylic acid cycle in Huntington disease and in a Huntington disease mouse model","volume":"74","author":"Naseri","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0315","doi-asserted-by":"crossref","unstructured":"Okado-Matsumoto, A., Fridovich, I., 2001. Subcellular distribution of superoxide dismutases (SOD) in rat liver: Cu,Zn-SOD in mitochondria. J. Biol. Chem. 276, 38388\u201338393.","DOI":"10.1074\/jbc.M105395200"},{"key":"10.1016\/j.mito.2019.03.004_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cell.2008.06.016","article-title":"A mitochondrial protein compendium elucidates complex I disease biology","volume":"134","author":"Pagliarini","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mito.2019.03.004_bb0325","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mito.2019.03.004_bb0330","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1074\/jbc.M113.492587","article-title":"Down-regulation of mortalin exacerbates Abeta-mediated mitochondrial fragmentation and dysfunction","volume":"289","author":"Park","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mito.2019.03.004_bb0335","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.13165","article-title":"Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's disease","volume":"134","author":"Pellman","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0340","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mito.2019.03.004_bb0345","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","article-title":"Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes","volume":"25","author":"Polyzos","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0350","doi-asserted-by":"crossref","unstructured":"Poole, L.B., 2007. The catalytic mechanism of Peroxiredoxins, in: Floh\u00e9, L., Harris, J.R. (Eds.), Peroxiredoxin systems. Springer; New York pp. 61-81.","DOI":"10.1007\/978-1-4020-6051-9_4"},{"key":"10.1016\/j.mito.2019.03.004_bb0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jnc.13719","article-title":"Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease","volume":"139","author":"Rodrigues","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mito.2019.03.004_bb0360","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: an evolving and intricate story","volume":"69","author":"Rosas","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0365","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/hmg\/ddt466","article-title":"DJ-1 modulates aggregation and pathogenesis in models of Huntington's disease","volume":"23","author":"Sajjad","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1010911417383","article-title":"Comparative analysis of superoxide dismutase activity between acute pharmacological models and a transgenic mouse model of Huntington's disease","volume":"26","author":"Santamaria","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.mito.2019.03.004_bb0375","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/371768a0","article-title":"Mitochondrial Hsp70\/MIM44 complex facilitates protein import","volume":"371","author":"Schneider","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.mito.2019.03.004_bb0380","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mito.2015.12.005","article-title":"Mitochondrial Hspa9\/Mortalin regulates erythroid differentiation via iron-sulfur cluster assembly","volume":"26","author":"Shan","year":"2016","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mito.2019.03.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020362","article-title":"DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation","volume":"2","author":"Shendelman","year":"2004","journal-title":"PLoS Biol."},{"key":"10.1016\/j.mito.2019.03.004_bb0390","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/nen.0b013e318163354a","article-title":"Mortalin: a protein associated with progression of Parkinson disease?","volume":"67","author":"Shi","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0395","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0400","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","article-title":"Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease","volume":"21","author":"Shirendeb","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0405","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0410","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0415","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","article-title":"Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice","volume":"1762","author":"Smith","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mito.2019.03.004_bb0420","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.mito.2019.03.004_bb0425","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.mito.2019.03.004_bb0430","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mito.2019.03.004_bb0435","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mito.2019.03.004_bb0440","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mito.2019.03.004_bb0445","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nprot.2006.234","article-title":"Two-dimensional difference gel electrophoresis","volume":"1","author":"Viswanathan","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.mito.2019.03.004_bb0450","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0455","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mito.2019.03.004_bb0460","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mito.2019.03.004_bb0465","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1074\/mcp.M800277-MCP200","article-title":"A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for Huntington disease","volume":"8","author":"Zabel","year":"2009","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Mitochondrion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724918300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567724918300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:22:42Z","timestamp":1761589362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567724918300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":93,"alternative-id":["S1567724918300758"],"URL":"https:\/\/doi.org\/10.1016\/j.mito.2019.03.004","relation":{},"ISSN":["1567-7249"],"issn-type":[{"value":"1567-7249","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel proteomic changes in brain mitochondria provide insights into mitochondrial dysfunction in mouse models of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Mitochondrion","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mito.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and Mitochondria Research Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}